chr19-12924708-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004461.3(FARSA):c.1126G>T(p.Val376Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00173 in 1,595,294 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0037 ( 14 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 33 hom. )
Consequence
FARSA
NM_004461.3 missense
NM_004461.3 missense
Scores
1
3
14
Clinical Significance
Conservation
PhyloP100: 4.65
Genes affected
FARSA (HGNC:3592): (phenylalanyl-tRNA synthetase subunit alpha) Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. This gene encodes a product which is similar to the catalytic subunit of prokaryotic and Saccharomyces cerevisiae phenylalanyl-tRNA synthetases (PheRS). This gene product has been shown to be expressed in a tumor-selective and cell cycle stage- and differentiation-dependent manner, the first member of the tRNA synthetase gene family shown to exhibit this type of regulated expression [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0105448365).
BP6
Variant 19-12924708-C-A is Benign according to our data. Variant chr19-12924708-C-A is described in ClinVar as [Benign]. Clinvar id is 3034463.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00372 (566/152328) while in subpopulation EAS AF= 0.0263 (136/5178). AF 95% confidence interval is 0.024. There are 14 homozygotes in gnomad4. There are 346 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FARSA | NM_004461.3 | c.1126G>T | p.Val376Leu | missense_variant | 10/13 | ENST00000314606.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FARSA | ENST00000314606.9 | c.1126G>T | p.Val376Leu | missense_variant | 10/13 | 1 | NM_004461.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00373 AC: 567AN: 152210Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
567
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00662 AC: 1589AN: 240094Hom.: 24 AF XY: 0.00557 AC XY: 720AN XY: 129196
GnomAD3 exomes
AF:
AC:
1589
AN:
240094
Hom.:
AF XY:
AC XY:
720
AN XY:
129196
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00153 AC: 2201AN: 1442966Hom.: 33 Cov.: 34 AF XY: 0.00140 AC XY: 1004AN XY: 714880
GnomAD4 exome
AF:
AC:
2201
AN:
1442966
Hom.:
Cov.:
34
AF XY:
AC XY:
1004
AN XY:
714880
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00372 AC: 566AN: 152328Hom.: 14 Cov.: 32 AF XY: 0.00465 AC XY: 346AN XY: 74488
GnomAD4 genome
AF:
AC:
566
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
346
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
612
Asia WGS
AF:
AC:
42
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
FARSA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;N
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N
REVEL
Benign
Sift
Benign
.;T;T
Sift4G
Benign
T;T;T
Polyphen
0.079
.;.;B
Vest4
MutPred
0.48
.;.;Gain of sheet (P = 0.0827);
MVP
MPC
0.50
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at